0.280
0.02 (6.14%)
| Previous Close | 0.264 |
| Open | 0.250 |
| Volume | 2,214,575 |
| Avg. Volume (3M) | 5,087,404 |
| Market Cap | 8,508,818 |
| Price / Earnings (Forward) | 16.61 |
| Price / Sales | 0.060 |
| Price / Book | 34.84 |
| 52 Weeks Range | |
| Earnings Date | 18 Nov 2025 |
| Profit Margin | -4.30% |
| Operating Margin (TTM) | -49.28% |
| Diluted EPS (TTM) | -0.240 |
| Quarterly Revenue Growth (YOY) | -42.90% |
| Quarterly Earnings Growth (YOY) | -33.70% |
| Total Debt/Equity (MRQ) | 351.59% |
| Current Ratio (MRQ) | 3.46 |
| Operating Cash Flow (TTM) | 12.72 M |
| Levered Free Cash Flow (TTM) | 7.68 M |
| Return on Assets (TTM) | -4.11% |
| Return on Equity (TTM) | -27.52% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Distribution (US) | Mixed | Bullish |
| Medical Distribution (Global) | Mixed | Bullish | |
| Stock | Zynex, Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | 0.0 |
| Relative Valuation | -5.0 |
| Financial Health | NA |
| Macro Environment | -0.3 |
| AI Insight | NA |
| Weighted Average | -1.28 |
Select this tab to load the latest available analysis.
|
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others. |
|
| Sector | Healthcare |
| Industry | Medical Distribution |
| Investment Style | Small Core |
| % Held by Insiders | 48.37% |
| % Held by Institutions | 22.92% |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |